| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Total patient revenue, net | ||||||||
- | - | 14,155 | 12,325 | - | 6,637 | 0 | 0 | 0 |
Total revenue | ||||||||
15,677 | 15,126 | 14,155 | 12,325 | 9,203 | 6,701 | 0 | 0 | 0 |
Operating expenses: | ||||||||
Patient expenses | ||||||||
2,484 | 2,540 | 2,822 | 2,212 | 1,332 | 933 | 0 | 0 | 0 |
Salaries and benefits | ||||||||
11,384 | 10,523 | 9,556 | 8,352 | 6,347 | 4,730 | 0 | 0 | 0 |
Share-based compensation | ||||||||
469 | 392 | 292 | 182 | 14 | 14 | 0 | 0 | 0 |
Advertising and marketing | ||||||||
1,133 | 1,238 | 1,403 | 1,377 | 1,113 | 859 | 0 | 0 | 0 |
General and administrative | ||||||||
5,323 | 5,064 | 4,800 | 4,493 | 3,800 | 3,063 | 0 | 0 | 0 |
Depreciation and amortization | ||||||||
1,717 | 1,552 | 1,211 | 1,213 | 905 | 651 | 0 | 0 | 0 |
Total operating expenses | ||||||||
22,512 | 21,311 | 20,086 | 17,831 | 13,515 | 10,252 | 0 | 0 | 0 |
Operating loss | ||||||||
-6,834 | -6,185 | -5,931 | -5,506 | -4,312 | -3,551 | 0 | 0 | 0 |
Other expenses: | ||||||||
Interest income | ||||||||
- | - | 0 | 0 | - | 7 | 0 | 0 | 0 |
Other expenses | ||||||||
- | -16 | 1 | 0 | 0 | - | - | 0 | - |
Beneficial conversion interest expense | ||||||||
- | 639 | 0 | 0 | 0 | - | - | - | - |
Interest expense | ||||||||
304 | 258 | 242 | 213 | 160 | 153 | 0 | 0 | 0 |
Total other expenses | ||||||||
-156 | -765 | -896 | -865 | -793 | -127 | 0 | 0 | 0 |
Loss before equity in earnings (loss) of non-consolidated affiliate | ||||||||
- | - | -6,827 | -6,371 | - | -3,679 | 0 | 0 | 0 |
Equity in earnings (loss) of non-consolidated affiliate | ||||||||
- | - | - | - | - | -105 | 0 | 0 | 0 |
Net loss before income taxes | ||||||||
-6,991 | -6,951 | -6,827 | -6,371 | -5,125 | -3,784 | 0 | 0 | 0 |
Net loss | ||||||||
-6,991 | -6,951 | -6,827 | -6,371 | -5,125 | -3,784 | 0 | 0 | 0 |
Net loss attributable to the non-controlling interest | ||||||||
359 | 454 | 1,483 | 1,369 | 1,447 | 731 | 0 | 0 | 0 |
Net loss attributable to IMAC Holdings, Inc. | ||||||||
-6,631 | -6,497 | -5,986 | -5,417 | -4,248 | -3,053 | 0 | 0 | 0 |
Net loss per share attributable to common stockholders Basic and diluted | ||||||||
-0.18 | -0.15 | -0.19 | -0.23 | -0.27 | 0.00 | -0.22 | -0.16 | -0.09 |
Weighted average common shares outstanding Basic and diluted | ||||||||
9,611 | 8,622 | 8,366 | 8,106 | 5,919 | 4,533 | 4,533 | 4,533 | 4,533 |
Patient Revenues, Net [Member] | ||||||||
Total revenue | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Patient Revenues [Member] | ||||||||
Total patient revenue, net | ||||||||
- | - | 33,005 | 30,365 | - | 16,135 | 0 | 0 | 0 |
Contractual Adjustments [Member] | ||||||||
Total patient revenue, net | ||||||||
- | - | -18,849 | -18,040 | - | -9,498 | 0 | 0 | 0 |
Management Fees [Member] | ||||||||
Total patient revenue, net | ||||||||
- | - | - | - | - | - | - | 0 | - |
Total revenue | ||||||||
0 | - | - | - | - | - | - | - | 0 |